Bausch Health
BHC
#4212
Rank
โ‚น231.80 B
Marketcap
โ‚น624.90
Share price
-6.10%
Change (1 day)
-12.76%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2025 (TTM): โ‚น84.70

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is โ‚น87.47. In 2024 the company made an earnings per share (EPS) of -โ‚น10.82 an increase over its 2023 EPS that were of -โ‚น146.08.

EPS history for Bausch Health from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น84.70-882.77%
2024-โ‚น10.82-92.59%
2023-โ‚น146.08160.89%
2022-โ‚น55.99-76.64%
2021-โ‚น239.6868.45%
2020-โ‚น142.28-68.91%
2019-โ‚น457.62-57.11%
2018-โ‚น1,067-272.22%
2017โ‚น619.59-199.29%
2016-โ‚น623.99798.7%
2015-โ‚น69.43-128.31%
2014โ‚น245.27-204.62%
2013-โ‚น234.45602.7%
2012-โ‚น33.36

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
-โ‚น85.66-197.94%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-โ‚น21.64-124.74%๐Ÿ‡บ๐Ÿ‡ธ USA